Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Published online before print March 11, 2009, doi:10.1212/01.wnl.0000346517.98982.1b)
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
01.wnl.0000346517.98982.1bv1
72/22/1886    most recent
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Google Scholar
Right arrow Articles by Nichols, W. C.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nichols, W. C.
Related Collections
Right arrow Parkinson's disease/Parkinsonism
Right arrow Genetic linkage
Right arrow Association studies in genetics
Right arrowRelated Article
NEUROLOGY 2009;72:1886-1892
© 2009 American Academy of Neurology

Variation in GIGYF2 is not associated with Parkinson disease

W. C. Nichols, PhD, D. K. Kissell, BS, N. Pankratz, PhD, M. W. Pauciulo, MBA, V. E. Elsaesser, BS, K. A. Clark, BS, C. A. Halter, MS, A. Rudolph, PhD, J. Wojcieszek, MD, R. F. Pfeiffer, MD, T. Foroud, PhD For the Parkinson Study Group–PROGENI Investigators*

From Cincinnati Children’s Hospital Medical Center (W.C.N., D.K.K., M.W.P., V.E.E., K.A.C.), OH; University of Cincinnati School of Medicine (W.C.N.), OH; Indiana University Medical Center (N.P., C.A.H., J.W., T.F.), Indianapolis; University of Rochester (A.R.), NY; and University of Tennessee Health Science Center (R.F.P.), Memphis.

Address correspondence and reprint requests to Dr. William C. Nichols, Division of Human Genetics, Cincinnati Children’s Hospital Medical Center, 3333 Burnet Avenue, Cincinnati, OH 45229 bill.nichols{at}cchmc.org

Objective: A recent study reported that mutations in a gene on chromosome 2q36-37, GIGYF2, result in Parkinson disease (PD). We have previously reported linkage to this chromosomal region in a sample of multiplex PD families, with the strongest evidence of linkage obtained using the subset of the sample having the strongest family history of disease and meeting the strictest diagnostic criteria. We have tested whether mutations in GIGYF2 may account for the previously observed linkage finding.

Methods: We sequenced the GIGYF2 coding region in 96 unrelated patients with PD used in our original study that contributed to the chromosome 2q36-37 linkage signal. Subsequently, we genotyped the entire sample of 566 multiplex PD kindreds as well as 1,447 controls to test whether variants in GIGYF2 are causative or increase susceptibility for PD.

Results: We detected three novel variants as well as one of the previously reported seven variants in a total of five multiple PD families; however, there was no consistent evidence that these variants segregated with PD in these families. We also did not find a significant increase in risk for PD among those inheriting variants in GIGYF2 (p = 0.28).

Conclusions: We believe that variation in a gene other than GIGYF2 accounts for the previously reported linkage finding on chromosome 2q36-37.

GDS = Geriatric Depression Scale; MMSE = Mini-Mental State Examination; NCRAD = National Cell Repository for Alzheimer’s Disease; PD = Parkinson disease; PSG = Parkinson Study Group; UPDRS = Unified Parkinson’s Disease Rating Scale.


Supplemental data at www.neurology.org

Editorial, page 1882

e-Pub ahead of print on March 11, 2009, at www.neurology.org.

*The Parkinson Study Group–PROGENI Investigators are listed in the appendix.

Supported by R01 NS37167, MO1 RR-00750. Control samples and clinical data were provided by the National Cell Repository for Alzheimer’s Disease (U24 AG021886) and the National Institute of Neurological Disorders and Stroke Human Genetics Resource Center DNA and Cell Line Repository (http://ccr.coriell.org/ninds).

Disclosure: The authors report no disclosures.

Medical Devices: 3730xl DNA Analyzer (Applied Biosystems, Foster City, CA).

Received July 8, 2008. Accepted in final form December 30, 2008.


Related Article

Variation on a theme: Identifying sequence variation in disease genes and defining pathogenicity
Lorraine N. Clark
Neurology 2009 72: 1882-1883. [Full Text] [PDF]



This article has been cited by other articles:


Home page
Hum Mol GenetHome page
B. Giovannone, W. G. Tsiaras, S. de la Monte, J. Klysik, C. Lautier, G. Karashchuk, S. Goldwurm, and R. J. Smith
GIGYF2 gene disruption in mice results in neurodegeneration and altered insulin-like growth factor signaling
Hum. Mol. Genet., December 1, 2009; 18(23): 4629 - 4639.
[Abstract] [Full Text] [PDF]


Home page
JWatch NeurologyHome page
Insufficient Evidence: A Retrial for a Suspected Parkinson Gene
Journal Watch Neurology, September 1, 2009; 2009(901): 1 - 1.
[Full Text]


Home page
NeurologyHome page
L. N. Clark
Variation on a theme: Identifying sequence variation in disease genes and defining pathogenicity
Neurology, June 2, 2009; 72(22): 1882 - 1883.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2009 by AAN Enterprises, Inc.